Macitentan 10mg tablets
NHS hospitals in England used £43,010,361 of indicative cost of Macitentan 10mg tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 10.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Macitentan 10mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Macitentan 10mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Sheffield Teaching Hospitals Nhs Trust | £10,116,005 |
| Royal Free London Nhs Foundation Trust | £9,323,737 |
| Guy's & St Thomas' Nhs Foundation Trust | £9,234,438 |
| Imperial College Healthcare Nhs Trust | £6,671,379 |
| Royal Papworth Hospital Nhs Ft | £4,228,537 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,598,068 |
| Manchester University Nhs Ft | £680,273 |
| University Hospital Southampton Nhs Ft | £534,995 |
| Hull And East Yorkshire Hpls Nhs Trust | £262,885 |
| Univ Hpl B/Ham Nhs Foundation Trust | £8,071 |
The primary-care picture
Macitentan is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Macitentan medicine page.